<DOC>
	<DOCNO>NCT01847599</DOCNO>
	<brief_summary>The purpose study evaluate efficacy implementation educational program adherence capecitabine alone combination lapatinib .</brief_summary>
	<brief_title>Educational Intervention Adherence Patients Treated Capecitabine +/- Lapatinib</brief_title>
	<detailed_description>200 subject meet inclusion/exclusion criterion treat capecitabine +/- lapatinib , enrol study . Adherence treatment subject assess first adherence evaluation period 3 cycle order identify patient need educational intervention ( non adherent patient ) . Only nonadherent patient ( adherence rate &lt; 80 % ) receive education intervention . During educational program , efficacy implementation educational program adherence capecitabine alone combination lapatinib evaluate 6 subsequent cycle .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Lapatinib</mesh_term>
	<criteria>Age &gt; 18 year histologically confirm breast cancer colorectal cancer Patient start oral treatment : capecitabine alone combination lapatinib ( include first cycle first 2 cycle ) . Volunteer participate study . ambulatory treat patient Able read , write understand French . Subject accept use MEMS monitor automatically compile drug dose history Written inform consent 3 metastatic chemotherapy severe concomitant condition make undesirable patient participate study would jeopardize adherence trial protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>educational intervention</keyword>
	<keyword>adherence</keyword>
	<keyword>capecitabine</keyword>
	<keyword>lapatinib</keyword>
</DOC>